ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HIC1
|
ENSG00000177374.8 | HIC1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HIC1 | hg19_v2_chr17_+_1959369_1959604, hg19_v2_chr17_+_1958388_1958404 | 0.21 | 4.4e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_224903995 | 6.98 |
ENST00000409304.1 ENST00000454956.1 ENST00000258405.4 |
SERPINE2 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
chr11_-_2160611 | 4.23 |
ENST00000416167.2 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr3_-_79068594 | 3.84 |
ENST00000436010.2 |
ROBO1 |
roundabout, axon guidance receptor, homolog 1 (Drosophila) |
chr10_-_17659357 | 3.54 |
ENST00000326961.6 ENST00000361271.3 |
PTPLA |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr2_+_235860616 | 3.51 |
ENST00000392011.2 |
SH3BP4 |
SH3-domain binding protein 4 |
chr1_-_85930823 | 3.46 |
ENST00000284031.8 ENST00000539042.1 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
chr2_-_161264385 | 3.37 |
ENST00000409972.1 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
chr3_-_185542761 | 3.22 |
ENST00000457616.2 ENST00000346192.3 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
chr3_-_49395892 | 2.97 |
ENST00000419783.1 |
GPX1 |
glutathione peroxidase 1 |
chr2_+_9346892 | 2.97 |
ENST00000281419.3 ENST00000315273.4 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
chr3_-_185542817 | 2.93 |
ENST00000382199.2 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
chr16_+_56642489 | 2.85 |
ENST00000561491.1 |
MT2A |
metallothionein 2A |
chr7_+_130131907 | 2.82 |
ENST00000223215.4 ENST00000437945.1 |
MEST |
mesoderm specific transcript |
chr8_-_41166953 | 2.82 |
ENST00000220772.3 |
SFRP1 |
secreted frizzled-related protein 1 |
chr6_-_132272504 | 2.79 |
ENST00000367976.3 |
CTGF |
connective tissue growth factor |
chr13_+_98795505 | 2.79 |
ENST00000319562.6 |
FARP1 |
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
chr19_-_18717627 | 2.71 |
ENST00000392386.3 |
CRLF1 |
cytokine receptor-like factor 1 |
chr10_+_124221036 | 2.66 |
ENST00000368984.3 |
HTRA1 |
HtrA serine peptidase 1 |
chr11_-_12030905 | 2.66 |
ENST00000326932.4 |
DKK3 |
dickkopf WNT signaling pathway inhibitor 3 |
chr2_-_1748214 | 2.65 |
ENST00000433670.1 ENST00000425171.1 ENST00000252804.4 |
PXDN |
peroxidasin homolog (Drosophila) |
chr10_-_17659234 | 2.60 |
ENST00000466335.1 |
PTPLA |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr4_-_22517620 | 2.60 |
ENST00000502482.1 ENST00000334304.5 |
GPR125 |
G protein-coupled receptor 125 |
chr10_+_75670862 | 2.57 |
ENST00000446342.1 ENST00000372764.3 ENST00000372762.4 |
PLAU |
plasminogen activator, urokinase |
chr1_-_95392635 | 2.56 |
ENST00000538964.1 ENST00000394202.4 ENST00000370206.4 |
CNN3 |
calponin 3, acidic |
chr16_-_65155833 | 2.51 |
ENST00000566827.1 ENST00000394156.3 ENST00000562998.1 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr13_-_110959478 | 2.50 |
ENST00000543140.1 ENST00000375820.4 |
COL4A1 |
collagen, type IV, alpha 1 |
chr13_+_110959598 | 2.50 |
ENST00000360467.5 |
COL4A2 |
collagen, type IV, alpha 2 |
chr22_+_33197683 | 2.50 |
ENST00000266085.6 |
TIMP3 |
TIMP metallopeptidase inhibitor 3 |
chr11_+_12399071 | 2.47 |
ENST00000539723.1 ENST00000550549.1 |
PARVA |
parvin, alpha |
chr3_-_149688502 | 2.29 |
ENST00000481767.1 ENST00000475518.1 |
PFN2 |
profilin 2 |
chr3_-_149688655 | 2.23 |
ENST00000461930.1 ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2 |
profilin 2 |
chr17_-_78009647 | 2.21 |
ENST00000310924.2 |
TBC1D16 |
TBC1 domain family, member 16 |
chr11_+_101981169 | 2.07 |
ENST00000526343.1 ENST00000282441.5 ENST00000537274.1 ENST00000345877.2 |
YAP1 |
Yes-associated protein 1 |
chr13_+_98795434 | 1.94 |
ENST00000376586.2 |
FARP1 |
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
chr3_-_49395705 | 1.91 |
ENST00000419349.1 |
GPX1 |
glutathione peroxidase 1 |
chr2_+_46524537 | 1.88 |
ENST00000263734.3 |
EPAS1 |
endothelial PAS domain protein 1 |
chr1_-_94703118 | 1.86 |
ENST00000260526.6 ENST00000370217.3 |
ARHGAP29 |
Rho GTPase activating protein 29 |
chr10_-_33625154 | 1.81 |
ENST00000265371.4 |
NRP1 |
neuropilin 1 |
chr3_-_149688896 | 1.81 |
ENST00000239940.7 |
PFN2 |
profilin 2 |
chr3_-_127541679 | 1.79 |
ENST00000265052.5 |
MGLL |
monoglyceride lipase |
chr11_+_69455855 | 1.78 |
ENST00000227507.2 ENST00000536559.1 |
CCND1 |
cyclin D1 |
chr10_+_124134201 | 1.75 |
ENST00000368990.3 ENST00000368988.1 ENST00000368989.2 ENST00000463663.2 |
PLEKHA1 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
chr9_+_124030338 | 1.75 |
ENST00000449773.1 ENST00000432226.1 ENST00000436847.1 ENST00000394353.2 ENST00000449733.1 ENST00000412819.1 ENST00000341272.2 ENST00000373808.2 |
GSN |
gelsolin |
chr8_+_136469684 | 1.75 |
ENST00000355849.5 |
KHDRBS3 |
KH domain containing, RNA binding, signal transduction associated 3 |
chr2_+_20646824 | 1.74 |
ENST00000272233.4 |
RHOB |
ras homolog family member B |
chr15_+_63340647 | 1.74 |
ENST00000404484.4 |
TPM1 |
tropomyosin 1 (alpha) |
chr9_+_504674 | 1.73 |
ENST00000382297.2 |
KANK1 |
KN motif and ankyrin repeat domains 1 |
chr11_+_13299186 | 1.73 |
ENST00000527998.1 ENST00000396441.3 ENST00000533520.1 ENST00000529825.1 ENST00000389707.4 ENST00000401424.1 ENST00000529388.1 ENST00000530357.1 ENST00000403290.1 ENST00000361003.4 ENST00000389708.3 ENST00000403510.3 ENST00000482049.1 |
ARNTL |
aryl hydrocarbon receptor nuclear translocator-like |
chr10_+_63661053 | 1.69 |
ENST00000279873.7 |
ARID5B |
AT rich interactive domain 5B (MRF1-like) |
chr12_+_6308881 | 1.67 |
ENST00000382518.1 ENST00000536586.1 |
CD9 |
CD9 molecule |
chr1_-_98386543 | 1.65 |
ENST00000423006.2 ENST00000370192.3 ENST00000306031.5 |
DPYD |
dihydropyrimidine dehydrogenase |
chr5_-_57756087 | 1.62 |
ENST00000274289.3 |
PLK2 |
polo-like kinase 2 |
chr12_+_6309517 | 1.60 |
ENST00000382519.4 ENST00000009180.4 |
CD9 |
CD9 molecule |
chr10_-_13342097 | 1.59 |
ENST00000263038.4 |
PHYH |
phytanoyl-CoA 2-hydroxylase |
chr1_+_169075554 | 1.58 |
ENST00000367815.4 |
ATP1B1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr20_-_50384864 | 1.57 |
ENST00000311637.5 ENST00000402822.1 |
ATP9A |
ATPase, class II, type 9A |
chr12_-_123755639 | 1.55 |
ENST00000535979.1 |
CDK2AP1 |
cyclin-dependent kinase 2 associated protein 1 |
chr7_-_30029367 | 1.55 |
ENST00000242059.5 |
SCRN1 |
secernin 1 |
chr12_-_124457371 | 1.53 |
ENST00000238156.3 ENST00000545037.1 |
CCDC92 |
coiled-coil domain containing 92 |
chr1_-_33815486 | 1.51 |
ENST00000373418.3 |
PHC2 |
polyhomeotic homolog 2 (Drosophila) |
chr6_-_138428613 | 1.50 |
ENST00000421351.3 |
PERP |
PERP, TP53 apoptosis effector |
chr20_-_50385138 | 1.48 |
ENST00000338821.5 |
ATP9A |
ATPase, class II, type 9A |
chr8_+_97506033 | 1.44 |
ENST00000518385.1 |
SDC2 |
syndecan 2 |
chr5_-_72744336 | 1.44 |
ENST00000499003.3 |
FOXD1 |
forkhead box D1 |
chr15_+_63340553 | 1.43 |
ENST00000334895.5 |
TPM1 |
tropomyosin 1 (alpha) |
chr18_+_21269404 | 1.42 |
ENST00000313654.9 |
LAMA3 |
laminin, alpha 3 |
chr8_+_26435359 | 1.42 |
ENST00000311151.5 |
DPYSL2 |
dihydropyrimidinase-like 2 |
chrX_+_154611749 | 1.42 |
ENST00000369505.3 |
F8A2 |
coagulation factor VIII-associated 2 |
chr2_-_175870085 | 1.41 |
ENST00000409156.3 |
CHN1 |
chimerin 1 |
chr15_+_63340858 | 1.41 |
ENST00000560615.1 |
TPM1 |
tropomyosin 1 (alpha) |
chr12_-_53574376 | 1.40 |
ENST00000267085.4 ENST00000379850.3 ENST00000379846.1 ENST00000424990.1 |
CSAD |
cysteine sulfinic acid decarboxylase |
chr12_-_47473425 | 1.39 |
ENST00000550413.1 |
AMIGO2 |
adhesion molecule with Ig-like domain 2 |
chr15_+_63340775 | 1.39 |
ENST00000559281.1 ENST00000317516.7 |
TPM1 |
tropomyosin 1 (alpha) |
chr3_+_138067521 | 1.39 |
ENST00000494949.1 |
MRAS |
muscle RAS oncogene homolog |
chr7_-_80548667 | 1.38 |
ENST00000265361.3 |
SEMA3C |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
chr9_-_21974820 | 1.37 |
ENST00000579122.1 ENST00000498124.1 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
chr2_+_201171064 | 1.37 |
ENST00000451764.2 |
SPATS2L |
spermatogenesis associated, serine-rich 2-like |
chr14_-_74960030 | 1.35 |
ENST00000553490.1 ENST00000557510.1 |
NPC2 |
Niemann-Pick disease, type C2 |
chr10_+_128593978 | 1.35 |
ENST00000280333.6 |
DOCK1 |
dedicator of cytokinesis 1 |
chr6_+_29910301 | 1.35 |
ENST00000376809.5 ENST00000376802.2 |
HLA-A |
major histocompatibility complex, class I, A |
chr17_-_3571934 | 1.34 |
ENST00000225525.3 |
TAX1BP3 |
Tax1 (human T-cell leukemia virus type I) binding protein 3 |
chr21_+_46825032 | 1.32 |
ENST00000400337.2 |
COL18A1 |
collagen, type XVIII, alpha 1 |
chr6_+_139456226 | 1.32 |
ENST00000367658.2 |
HECA |
headcase homolog (Drosophila) |
chr3_-_123304017 | 1.31 |
ENST00000383657.5 |
PTPLB |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b |
chr8_-_145013711 | 1.30 |
ENST00000345136.3 |
PLEC |
plectin |
chr2_+_201171242 | 1.29 |
ENST00000360760.5 |
SPATS2L |
spermatogenesis associated, serine-rich 2-like |
chr7_-_151329416 | 1.29 |
ENST00000418337.2 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
chr12_+_26274917 | 1.29 |
ENST00000538142.1 |
SSPN |
sarcospan |
chr22_-_50746027 | 1.29 |
ENST00000425954.1 ENST00000449103.1 |
PLXNB2 |
plexin B2 |
chr1_+_86046433 | 1.28 |
ENST00000451137.2 |
CYR61 |
cysteine-rich, angiogenic inducer, 61 |
chr14_+_92980111 | 1.27 |
ENST00000216487.7 ENST00000557762.1 |
RIN3 |
Ras and Rab interactor 3 |
chr10_+_121485588 | 1.27 |
ENST00000361976.2 ENST00000369083.3 |
INPP5F |
inositol polyphosphate-5-phosphatase F |
chr1_-_21503337 | 1.26 |
ENST00000400422.1 ENST00000602326.1 ENST00000411888.1 ENST00000438975.1 |
EIF4G3 |
eukaryotic translation initiation factor 4 gamma, 3 |
chr2_+_173292390 | 1.26 |
ENST00000442250.1 ENST00000458358.1 ENST00000409080.1 |
ITGA6 |
integrin, alpha 6 |
chr11_+_70244510 | 1.26 |
ENST00000346329.3 ENST00000301843.8 ENST00000376561.3 |
CTTN |
cortactin |
chr10_-_125851961 | 1.25 |
ENST00000346248.5 |
CHST15 |
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
chr6_-_56819385 | 1.25 |
ENST00000370754.5 ENST00000449297.2 |
DST |
dystonin |
chr5_+_148521136 | 1.25 |
ENST00000506113.1 |
ABLIM3 |
actin binding LIM protein family, member 3 |
chr12_-_53574418 | 1.23 |
ENST00000379843.3 ENST00000453446.2 ENST00000437073.1 |
CSAD |
cysteine sulfinic acid decarboxylase |
chr2_+_201170770 | 1.23 |
ENST00000409988.3 ENST00000409385.1 |
SPATS2L |
spermatogenesis associated, serine-rich 2-like |
chr5_+_148521381 | 1.23 |
ENST00000504238.1 |
ABLIM3 |
actin binding LIM protein family, member 3 |
chr18_+_21269556 | 1.23 |
ENST00000399516.3 |
LAMA3 |
laminin, alpha 3 |
chr2_+_102314161 | 1.22 |
ENST00000425019.1 |
MAP4K4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
chr5_+_148521046 | 1.22 |
ENST00000326685.7 ENST00000356541.3 ENST00000309868.7 |
ABLIM3 |
actin binding LIM protein family, member 3 |
chr13_-_40177261 | 1.21 |
ENST00000379589.3 |
LHFP |
lipoma HMGIC fusion partner |
chr8_+_42995548 | 1.20 |
ENST00000458501.2 ENST00000379644.4 |
HGSNAT |
heparan-alpha-glucosaminide N-acetyltransferase |
chr7_-_24797032 | 1.20 |
ENST00000409970.1 ENST00000409775.3 |
DFNA5 |
deafness, autosomal dominant 5 |
chr6_+_31865552 | 1.19 |
ENST00000469372.1 ENST00000497706.1 |
C2 |
complement component 2 |
chr4_-_52904425 | 1.19 |
ENST00000535450.1 |
SGCB |
sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) |
chr2_+_201171372 | 1.18 |
ENST00000409140.3 |
SPATS2L |
spermatogenesis associated, serine-rich 2-like |
chr8_-_23261589 | 1.15 |
ENST00000524168.1 ENST00000523833.2 ENST00000519243.1 ENST00000389131.3 |
LOXL2 |
lysyl oxidase-like 2 |
chr10_-_126847276 | 1.14 |
ENST00000531469.1 |
CTBP2 |
C-terminal binding protein 2 |
chr3_-_52739762 | 1.13 |
ENST00000487642.1 ENST00000464705.1 ENST00000491606.1 ENST00000489119.1 ENST00000478968.2 |
GLT8D1 |
glycosyltransferase 8 domain containing 1 |
chr14_-_51411194 | 1.13 |
ENST00000544180.2 |
PYGL |
phosphorylase, glycogen, liver |
chr3_+_37903432 | 1.12 |
ENST00000443503.2 |
CTDSPL |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
chr1_-_225840747 | 1.12 |
ENST00000366843.2 ENST00000366844.3 |
ENAH |
enabled homolog (Drosophila) |
chr15_+_63340734 | 1.11 |
ENST00000560959.1 |
TPM1 |
tropomyosin 1 (alpha) |
chr14_-_51411146 | 1.10 |
ENST00000532462.1 |
PYGL |
phosphorylase, glycogen, liver |
chr9_-_13279563 | 1.10 |
ENST00000541718.1 |
MPDZ |
multiple PDZ domain protein |
chr2_-_175869936 | 1.09 |
ENST00000409900.3 |
CHN1 |
chimerin 1 |
chr2_-_20212422 | 1.08 |
ENST00000421259.2 ENST00000407540.3 |
MATN3 |
matrilin 3 |
chr5_-_175843524 | 1.08 |
ENST00000502877.1 |
CLTB |
clathrin, light chain B |
chr3_+_30648066 | 1.08 |
ENST00000359013.4 |
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa) |
chr15_-_83953466 | 1.07 |
ENST00000345382.2 |
BNC1 |
basonuclin 1 |
chr19_+_35521572 | 1.07 |
ENST00000262631.5 |
SCN1B |
sodium channel, voltage-gated, type I, beta subunit |
chrX_-_153151586 | 1.06 |
ENST00000370060.1 ENST00000370055.1 ENST00000420165.1 |
L1CAM |
L1 cell adhesion molecule |
chr9_-_112083229 | 1.06 |
ENST00000374566.3 ENST00000374557.4 |
EPB41L4B |
erythrocyte membrane protein band 4.1 like 4B |
chr9_-_88714421 | 1.06 |
ENST00000388712.3 |
GOLM1 |
golgi membrane protein 1 |
chr12_-_123756781 | 1.05 |
ENST00000544658.1 |
CDK2AP1 |
cyclin-dependent kinase 2 associated protein 1 |
chr2_+_30369859 | 1.05 |
ENST00000402003.3 |
YPEL5 |
yippee-like 5 (Drosophila) |
chr18_+_33877654 | 1.03 |
ENST00000257209.4 ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3 |
formin homology 2 domain containing 3 |
chr12_+_53693466 | 1.03 |
ENST00000267103.5 ENST00000548632.1 |
C12orf10 |
chromosome 12 open reading frame 10 |
chr2_-_106015527 | 1.02 |
ENST00000344213.4 ENST00000358129.4 |
FHL2 |
four and a half LIM domains 2 |
chr12_-_110318226 | 1.00 |
ENST00000544393.1 |
GLTP |
glycolipid transfer protein |
chr15_-_71146480 | 1.00 |
ENST00000299213.8 |
LARP6 |
La ribonucleoprotein domain family, member 6 |
chr7_-_134143841 | 1.00 |
ENST00000285930.4 |
AKR1B1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
chr5_-_175843569 | 0.99 |
ENST00000310418.4 ENST00000345807.2 |
CLTB |
clathrin, light chain B |
chr3_+_171758344 | 0.99 |
ENST00000336824.4 ENST00000423424.1 |
FNDC3B |
fibronectin type III domain containing 3B |
chr17_-_1389419 | 0.99 |
ENST00000575158.1 |
MYO1C |
myosin IC |
chr5_-_146889619 | 0.99 |
ENST00000343218.5 |
DPYSL3 |
dihydropyrimidinase-like 3 |
chr12_+_53491220 | 0.98 |
ENST00000548547.1 ENST00000301464.3 |
IGFBP6 |
insulin-like growth factor binding protein 6 |
chr12_+_119616447 | 0.98 |
ENST00000281938.2 |
HSPB8 |
heat shock 22kDa protein 8 |
chr3_+_57994127 | 0.98 |
ENST00000490882.1 ENST00000295956.4 ENST00000358537.3 ENST00000429972.2 ENST00000348383.5 ENST00000357272.4 |
FLNB |
filamin B, beta |
chr11_-_2160180 | 0.98 |
ENST00000381406.4 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr8_-_145018905 | 0.97 |
ENST00000398774.2 |
PLEC |
plectin |
chr21_-_28338732 | 0.97 |
ENST00000284987.5 |
ADAMTS5 |
ADAM metallopeptidase with thrombospondin type 1 motif, 5 |
chr20_+_4666882 | 0.96 |
ENST00000379440.4 ENST00000430350.2 |
PRNP |
prion protein |
chr2_+_217498105 | 0.96 |
ENST00000233809.4 |
IGFBP2 |
insulin-like growth factor binding protein 2, 36kDa |
chr12_-_110318263 | 0.95 |
ENST00000318348.4 |
GLTP |
glycolipid transfer protein |
chrX_-_100914781 | 0.95 |
ENST00000431597.1 ENST00000458024.1 ENST00000413506.1 ENST00000440675.1 ENST00000328766.5 ENST00000356824.4 |
ARMCX2 |
armadillo repeat containing, X-linked 2 |
chr17_-_64187973 | 0.95 |
ENST00000583358.1 ENST00000392769.2 |
CEP112 |
centrosomal protein 112kDa |
chr16_-_4987065 | 0.95 |
ENST00000590782.2 ENST00000345988.2 |
PPL |
periplakin |
chr16_-_18441131 | 0.95 |
ENST00000339303.5 |
NPIPA8 |
nuclear pore complex interacting protein family, member A8 |
chr15_+_101420028 | 0.95 |
ENST00000557963.1 ENST00000346623.6 |
ALDH1A3 |
aldehyde dehydrogenase 1 family, member A3 |
chr14_-_89883412 | 0.94 |
ENST00000557258.1 |
FOXN3 |
forkhead box N3 |
chr2_+_241938255 | 0.94 |
ENST00000401884.1 ENST00000405547.3 ENST00000310397.8 ENST00000342631.6 |
SNED1 |
sushi, nidogen and EGF-like domains 1 |
chr22_+_38142235 | 0.93 |
ENST00000407319.2 ENST00000403663.2 ENST00000428075.1 |
TRIOBP |
TRIO and F-actin binding protein |
chr12_-_123756687 | 0.93 |
ENST00000261692.2 |
CDK2AP1 |
cyclin-dependent kinase 2 associated protein 1 |
chr9_-_99381660 | 0.92 |
ENST00000375240.3 ENST00000463569.1 |
CDC14B |
cell division cycle 14B |
chr3_+_30647994 | 0.92 |
ENST00000295754.5 |
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa) |
chr9_+_131314859 | 0.92 |
ENST00000358161.5 ENST00000372731.4 ENST00000372739.3 |
SPTAN1 |
spectrin, alpha, non-erythrocytic 1 |
chr3_-_52001448 | 0.91 |
ENST00000461554.1 ENST00000395013.3 ENST00000428823.2 ENST00000483411.1 ENST00000461544.1 ENST00000355852.2 |
PCBP4 |
poly(rC) binding protein 4 |
chr3_+_50192499 | 0.90 |
ENST00000413852.1 |
SEMA3F |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr1_-_93426998 | 0.90 |
ENST00000370310.4 |
FAM69A |
family with sequence similarity 69, member A |
chr17_-_62658186 | 0.89 |
ENST00000262435.9 |
SMURF2 |
SMAD specific E3 ubiquitin protein ligase 2 |
chr8_-_125740730 | 0.89 |
ENST00000354184.4 |
MTSS1 |
metastasis suppressor 1 |
chr4_-_141677267 | 0.89 |
ENST00000442267.2 |
TBC1D9 |
TBC1 domain family, member 9 (with GRAM domain) |
chr3_+_12329358 | 0.88 |
ENST00000309576.6 |
PPARG |
peroxisome proliferator-activated receptor gamma |
chr20_-_61569296 | 0.88 |
ENST00000370371.4 |
DIDO1 |
death inducer-obliterator 1 |
chr7_+_98246588 | 0.87 |
ENST00000265634.3 |
NPTX2 |
neuronal pentraxin II |
chr10_+_120863587 | 0.86 |
ENST00000535029.1 ENST00000361432.2 ENST00000544016.1 |
FAM45A |
family with sequence similarity 45, member A |
chr2_-_242255117 | 0.86 |
ENST00000420451.1 ENST00000417540.1 ENST00000310931.4 |
HDLBP |
high density lipoprotein binding protein |
chr2_+_202899310 | 0.86 |
ENST00000286201.1 |
FZD7 |
frizzled family receptor 7 |
chr1_+_19970657 | 0.85 |
ENST00000375136.3 |
NBL1 |
neuroblastoma 1, DAN family BMP antagonist |
chr2_+_242255297 | 0.85 |
ENST00000401990.1 ENST00000407971.1 ENST00000436795.1 ENST00000411484.1 ENST00000434955.1 ENST00000402092.2 ENST00000441533.1 ENST00000443492.1 ENST00000437066.1 ENST00000429791.1 |
SEPT2 |
septin 2 |
chr1_+_17866290 | 0.85 |
ENST00000361221.3 ENST00000452522.1 ENST00000434513.1 |
ARHGEF10L |
Rho guanine nucleotide exchange factor (GEF) 10-like |
chr14_+_21152706 | 0.85 |
ENST00000397995.2 ENST00000304704.4 ENST00000553909.1 |
RNASE4 AL163636.6 |
ribonuclease, RNase A family, 4 Homo sapiens ribonuclease, RNase A family, 4 (RNASE4), transcript variant 4, mRNA. |
chr10_-_33246722 | 0.84 |
ENST00000437302.1 ENST00000396033.2 |
ITGB1 |
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
chrX_+_38420623 | 0.84 |
ENST00000378482.2 |
TSPAN7 |
tetraspanin 7 |
chr3_+_50192537 | 0.84 |
ENST00000002829.3 |
SEMA3F |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
chr2_+_238395803 | 0.84 |
ENST00000264605.3 |
MLPH |
melanophilin |
chr5_+_72921983 | 0.83 |
ENST00000296794.6 ENST00000545377.1 ENST00000513042.2 ENST00000287898.5 ENST00000509848.1 |
ARHGEF28 |
Rho guanine nucleotide exchange factor (GEF) 28 |
chr10_-_128077024 | 0.83 |
ENST00000368679.4 ENST00000368676.4 ENST00000448723.1 |
ADAM12 |
ADAM metallopeptidase domain 12 |
chr16_+_1662326 | 0.83 |
ENST00000397412.3 |
CRAMP1L |
Crm, cramped-like (Drosophila) |
chr17_-_48943706 | 0.83 |
ENST00000499247.2 |
TOB1 |
transducer of ERBB2, 1 |
chr3_+_179370517 | 0.82 |
ENST00000263966.3 |
USP13 |
ubiquitin specific peptidase 13 (isopeptidase T-3) |
chr20_+_48807351 | 0.82 |
ENST00000303004.3 |
CEBPB |
CCAAT/enhancer binding protein (C/EBP), beta |
chr9_-_21975038 | 0.82 |
ENST00000446177.1 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
chr3_-_52488048 | 0.82 |
ENST00000232975.3 |
TNNC1 |
troponin C type 1 (slow) |
chr1_-_236228417 | 0.82 |
ENST00000264187.6 |
NID1 |
nidogen 1 |
chr15_+_80696666 | 0.82 |
ENST00000303329.4 |
ARNT2 |
aryl-hydrocarbon receptor nuclear translocator 2 |
chr16_-_79634595 | 0.82 |
ENST00000326043.4 ENST00000393350.1 |
MAF |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog |
chr2_-_31360887 | 0.81 |
ENST00000420311.2 ENST00000356174.3 ENST00000324589.5 |
GALNT14 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
chr3_-_69435428 | 0.81 |
ENST00000542259.1 |
FRMD4B |
FERM domain containing 4B |
chr14_+_21152259 | 0.80 |
ENST00000555835.1 ENST00000336811.6 |
RNASE4 ANG |
ribonuclease, RNase A family, 4 angiogenin, ribonuclease, RNase A family, 5 |
chr7_-_150946015 | 0.79 |
ENST00000262188.8 |
SMARCD3 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
chr11_-_27494279 | 0.79 |
ENST00000379214.4 |
LGR4 |
leucine-rich repeat containing G protein-coupled receptor 4 |
chr9_-_21975088 | 0.79 |
ENST00000304494.5 |
CDKN2A |
cyclin-dependent kinase inhibitor 2A |
chr17_-_56032684 | 0.79 |
ENST00000577830.1 |
CUEDC1 |
CUE domain containing 1 |
chr12_-_109251345 | 0.79 |
ENST00000360239.3 ENST00000326495.5 ENST00000551165.1 |
SSH1 |
slingshot protein phosphatase 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 3.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.6 | 3.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 2.2 | GO:0008184 | purine nucleobase binding(GO:0002060) glycogen phosphorylase activity(GO:0008184) |
0.5 | 2.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.5 | 2.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.5 | 2.6 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.5 | 2.0 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.5 | 2.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.5 | 1.5 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.5 | 1.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.4 | 1.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.4 | 0.8 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 2.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.3 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 1.2 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.3 | 1.1 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.3 | 10.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 1.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.3 | 1.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 1.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.3 | 1.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 2.9 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.3 | 1.3 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 0.7 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 1.4 | GO:1903135 | cupric ion binding(GO:1903135) |
0.2 | 1.4 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.2 | 0.7 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 5.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 9.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 2.7 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 0.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 2.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.0 | GO:0070728 | leucine binding(GO:0070728) |
0.2 | 1.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 4.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 1.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 0.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 2.1 | GO:0050542 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.2 | 3.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 1.1 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.2 | 1.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 0.5 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.2 | 5.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 1.4 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.2 | 6.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.2 | 0.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 4.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.2 | 3.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 1.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.2 | 2.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.6 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.2 | 0.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 1.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.4 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.1 | 1.0 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 0.7 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 1.3 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 1.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 1.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.8 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 1.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.4 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.4 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 3.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.6 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.1 | 0.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 5.0 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 2.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.6 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.1 | 1.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 10.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.5 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 0.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 2.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 1.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 2.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.4 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.3 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
0.1 | 3.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.7 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 1.6 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.9 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.3 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 0.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.4 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.1 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.8 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 3.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 1.3 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 8.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 1.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.1 | 0.3 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 1.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 2.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 1.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 1.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 0.2 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.1 | 1.5 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 1.3 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.2 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 1.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.2 | GO:0030305 | heparanase activity(GO:0030305) |
0.1 | 0.4 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 0.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.1 | 0.2 | GO:0008940 | nitrate reductase activity(GO:0008940) molybdenum ion binding(GO:0030151) |
0.1 | 0.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 1.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 1.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 0.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 2.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.5 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.0 | 0.7 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 2.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.0 | 2.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.9 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.1 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.8 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.6 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 1.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.0 | 0.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.4 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.5 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 6.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.0 | 0.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.7 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 3.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.4 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 1.3 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.0 | 0.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.5 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 3.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 2.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.3 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.1 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.0 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.0 | 0.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.0 | 0.4 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 1.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 1.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 2.5 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.0 | 4.1 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.3 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.1 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.0 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0008481 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.0 | 0.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 0.7 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0035877 | death effector domain binding(GO:0035877) |
0.0 | 0.1 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 1.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.2 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.0 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.0 | 0.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 3.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.1 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.2 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 2.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.0 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.0 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.0 | 0.3 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 10.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 4.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.2 | 2.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 1.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 1.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 7.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 3.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 10.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 4.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 8.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 4.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 2.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 3.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 6.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 2.1 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.3 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 5.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 16.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 4.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 2.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 1.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 1.7 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 1.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 7.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 1.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 5.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.8 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 1.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.9 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.9 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 1.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 1.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 1.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.5 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 3.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.8 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.8 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 1.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 7.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.9 | 2.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.6 | 5.0 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.5 | 4.9 | GO:0097413 | Lewy body(GO:0097413) |
0.5 | 1.9 | GO:0031673 | H zone(GO:0031673) |
0.4 | 1.7 | GO:0045160 | myosin I complex(GO:0045160) |
0.4 | 1.3 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.4 | 7.1 | GO:0032059 | bleb(GO:0032059) |
0.4 | 2.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.3 | 2.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.3 | 0.8 | GO:0034680 | integrin alpha1-beta1 complex(GO:0034665) integrin alpha3-beta1 complex(GO:0034667) integrin alpha8-beta1 complex(GO:0034678) integrin alpha10-beta1 complex(GO:0034680) |
0.3 | 0.3 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.3 | 2.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.2 | 1.0 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 2.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 2.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 2.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 1.4 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.2 | 1.7 | GO:0033391 | chromatoid body(GO:0033391) |
0.2 | 2.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 2.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 1.2 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 1.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.1 | 0.3 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 1.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.8 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.1 | 0.8 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 1.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.7 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 1.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 1.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 1.8 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 1.6 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.9 | GO:0032010 | phagolysosome(GO:0032010) alveolar lamellar body(GO:0097208) |
0.1 | 2.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 3.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.3 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 1.5 | GO:0097227 | sperm annulus(GO:0097227) |
0.1 | 1.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.5 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 0.7 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 1.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 1.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 0.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 1.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 2.7 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.5 | GO:0035859 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.1 | 1.5 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 0.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.4 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.1 | 1.0 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 1.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 1.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.1 | 1.1 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.5 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 5.6 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 7.1 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 6.2 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 3.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.3 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 2.9 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.1 | 0.4 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 0.7 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 5.5 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 4.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.7 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 4.9 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 1.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.3 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.0 | 0.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 6.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 3.8 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.1 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 2.3 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
0.0 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 0.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 2.3 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 3.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 4.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 1.1 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.0 | 3.1 | GO:0005814 | centriole(GO:0005814) |
0.0 | 3.0 | GO:0070160 | occluding junction(GO:0070160) |
0.0 | 1.4 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 2.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.8 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.3 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 1.4 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.0 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 1.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.2 | GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.0 | 0.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.0 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 4.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 1.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 1.7 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 2.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.0 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 6.8 | GO:0061107 | seminal vesicle development(GO:0061107) |
1.3 | 3.8 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
1.0 | 4.9 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.9 | 2.8 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.9 | 2.8 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.9 | 7.1 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.9 | 2.6 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.8 | 3.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.7 | 2.8 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.7 | 2.0 | GO:0002514 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.7 | 2.7 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.7 | 2.6 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.7 | 7.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.6 | 2.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.6 | 2.5 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.6 | 2.9 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.6 | 5.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.5 | 1.6 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.5 | 1.6 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.5 | 2.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.5 | 2.1 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.5 | 2.1 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.5 | 2.0 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.5 | 1.0 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.5 | 2.0 | GO:0046836 | glycolipid transport(GO:0046836) |
0.5 | 1.4 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.4 | 4.0 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.4 | 1.7 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.4 | 0.9 | GO:0009996 | negative regulation of cell fate specification(GO:0009996) |
0.4 | 2.9 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.4 | 1.6 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.4 | 3.3 | GO:0009414 | response to water deprivation(GO:0009414) |
0.4 | 2.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.4 | 1.8 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.3 | 1.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.3 | 1.3 | GO:0061643 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
0.3 | 3.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.3 | 0.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.3 | 1.2 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.3 | 0.9 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.3 | 1.5 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.3 | 1.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 1.1 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.3 | 1.6 | GO:0030035 | microspike assembly(GO:0030035) |
0.3 | 1.3 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.3 | 3.4 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.3 | 2.9 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.3 | 1.1 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
0.3 | 0.3 | GO:0051604 | protein maturation(GO:0051604) |
0.3 | 1.3 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 1.0 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
0.3 | 1.8 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.3 | 2.8 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.3 | 1.8 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.7 | GO:1902955 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.2 | 6.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 1.4 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.2 | 1.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 0.7 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.2 | 0.9 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.2 | 0.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.2 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.2 | 0.9 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.2 | 1.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 2.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 1.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 0.8 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 1.4 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 1.2 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.2 | 0.4 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.2 | 0.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.2 | 1.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 0.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 0.9 | GO:0030047 | actin modification(GO:0030047) |
0.2 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.2 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.2 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.4 | GO:1901963 | regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) |
0.2 | 0.2 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.2 | 2.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 0.7 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 1.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.2 | 0.5 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
0.2 | 0.8 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
0.2 | 0.3 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.2 | 0.7 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.2 | 1.0 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.2 | 0.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.8 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
0.2 | 0.5 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.2 | 0.6 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.2 | 1.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 0.6 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.2 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 1.7 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.6 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 1.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.1 | 0.4 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.1 | 0.4 | GO:0071529 | cementum mineralization(GO:0071529) |
0.1 | 0.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.8 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.1 | 1.1 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.5 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.1 | 1.3 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 1.9 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.4 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.4 | GO:0050917 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
0.1 | 0.4 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 1.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.4 | GO:1990869 | beta selection(GO:0043366) regulation of modification of synaptic structure(GO:1905244) response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.1 | 1.3 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.1 | 0.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 1.5 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.7 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.1 | 1.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 4.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 2.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.1 | 0.2 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 2.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.1 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.1 | 1.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 1.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 1.2 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.1 | 1.0 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 3.0 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 1.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 1.4 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.1 | 0.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.4 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.1 | 0.4 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.1 | 0.7 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 2.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.3 | GO:0061030 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 | 1.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.3 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.1 | 0.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.1 | 1.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 0.5 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.1 | 0.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) positive regulation of gastrulation(GO:2000543) |
0.1 | 0.3 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.1 | 0.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.4 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.1 | 1.0 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.5 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.1 | 0.3 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.1 | 0.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 0.3 | GO:1904616 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.1 | 0.2 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.1 | 0.3 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.1 | 0.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.3 | GO:0035900 | response to isolation stress(GO:0035900) |
0.1 | 0.3 | GO:0008078 | apical constriction(GO:0003383) mesoderm migration involved in gastrulation(GO:0007509) mesodermal cell migration(GO:0008078) |
0.1 | 0.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.1 | 0.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.7 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
0.1 | 0.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.5 | GO:0046618 | drug export(GO:0046618) |
0.1 | 0.2 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.1 | 0.6 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.1 | 0.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 0.8 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.6 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.1 | 1.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.3 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
0.1 | 0.8 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.2 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.1 | 0.6 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.1 | 0.1 | GO:0032900 | regulation of neurotrophin production(GO:0032899) negative regulation of neurotrophin production(GO:0032900) |
0.1 | 1.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.2 | GO:0086073 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 0.2 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.1 | 0.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 1.0 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 0.4 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.9 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.5 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 1.2 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 1.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 1.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 1.8 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.1 | 1.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.4 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 1.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 2.1 | GO:0016577 | histone demethylation(GO:0016577) |
0.1 | 1.4 | GO:0010226 | response to lithium ion(GO:0010226) |
0.1 | 0.3 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.2 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.1 | 0.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.5 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.1 | 0.4 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.1 | 0.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.3 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.0 | 0.8 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0007113 | endomitotic cell cycle(GO:0007113) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.0 | 0.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.0 | 0.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.0 | 0.6 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 1.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.5 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.0 | 0.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.4 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.5 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.3 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.0 | 0.0 | GO:0060594 | mammary gland specification(GO:0060594) |
0.0 | 0.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.0 | 0.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0072114 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) pronephros morphogenesis(GO:0072114) |
0.0 | 0.2 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.0 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.0 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.0 | 3.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.3 | GO:0070831 | basement membrane assembly(GO:0070831) regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 | 0.3 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.0 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.2 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 2.1 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.3 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.0 | 3.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.1 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.0 | 0.3 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.0 | 0.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.1 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.0 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.0 | 0.1 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.5 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 1.9 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.0 | 0.4 | GO:0008406 | gonad development(GO:0008406) |
0.0 | 3.5 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 0.3 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.0 | 0.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.3 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 1.2 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 2.6 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.8 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.0 | 0.1 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:0014744 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of muscle adaptation(GO:0014744) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.0 | 0.2 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.0 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.0 | 0.1 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.0 | 0.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.2 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.6 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.0 | 0.5 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.0 | 0.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.0 | 0.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.1 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 0.3 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.0 | 1.0 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.5 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.0 | 0.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.2 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 1.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 2.1 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.0 | 0.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.0 | 0.3 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.1 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.0 | 0.6 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.0 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 0.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 0.1 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.0 | 1.0 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
0.0 | 0.2 | GO:0098969 | neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
0.0 | 0.0 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.0 | 0.3 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
0.0 | 1.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.1 | GO:0009217 | dGTP catabolic process(GO:0006203) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.0 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.3 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
0.0 | 0.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.1 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.0 | 0.7 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.3 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 1.1 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.0 | 0.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.0 | 0.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.8 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.7 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.2 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.0 | 0.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.0 | 0.1 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
0.0 | 0.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.1 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.3 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 0.1 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.0 | 0.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.1 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.0 | 0.4 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.0 | 0.1 | GO:0045861 | negative regulation of proteolysis(GO:0045861) |
0.0 | 0.7 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.3 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.1 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.0 | 1.1 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.0 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 0.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 1.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.0 | 0.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.0 | 0.2 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.0 | 0.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 1.4 | GO:0006720 | isoprenoid metabolic process(GO:0006720) |
0.0 | 0.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.3 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.1 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.3 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.0 | GO:0002384 | hepatic immune response(GO:0002384) |
0.0 | 0.2 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.3 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.0 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 1.0 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 4.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 7.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 6.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.2 | 11.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 1.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 4.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 6.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 1.7 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 5.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 1.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 3.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 7.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 2.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 2.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 3.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 6.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 2.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 4.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 2.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 0.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 2.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.7 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.6 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 1.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.1 | 1.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 2.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 6.6 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.7 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 2.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 1.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 2.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.4 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 2.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.7 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.4 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 2.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 1.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 2.2 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.1 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.0 | 0.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.0 | 0.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |